| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |